Search results

AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Over the

Investors interested in Industrial Products stocks should always be looking to find the best-performing companies in the group. ABB (ABBNY) is a stock that can certainly grab the attention of many

In the latest trading session, AbbVie (ABBV) closed at $232.35, marking a -1.63% move from the previous day. The stock's performance was behind the S&P 500's daily loss of 0.57%. Elsewhere, the Dow

A month has gone by since the last earnings report for AbbVie (ABBV). Shares have added about 6.1% in that time frame, outperforming the S&P 500.

Will the recent positive trend continue leading up

AbbVie (ABBV) stock felt some downward pressure despite reporting better-than-expected fourth-quarter results on Feb. 4. AbbVie beat estimates for both earnings and sales and also issued an upbeat

AbbVie ABBV announced encouraging fourth-quarter and full-year 2025 results earlier this month that beat expectations. A major portion of the company’s top-line growth came from its newer immunology

Investors interested in stocks from the Manufacturing - Electronics sector have probably already heard of Vestas Wind Systems AS (VWDRY) and ABB (ABBNY). But which of these two stocks is more

Johnson & Johnson JNJ and AbbVie ABBV are leading drugmakers with strong franchises in immunology, oncology and neuroscience. Beyond these areas, J&J also markets therapies for cardiovascular and

AbbVie ABBV reported encouraging fourth-quarter and full-year 2025 results last month. While the company’s immunology portfolio accounted for the bulk of revenue growth, its neuroscience franchise

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth

Tuesday, February 17, 2026The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including AbbVie

Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near

Among large-cap U.S. MedTech companies, Boston Scientific BSX and Abbott ABT continue to attract significant investor focus. Abbott’s business model is diversified, having leading businesses and

Founded in 1929, Lord Abbett is an independent, privately held global investment management firm. As of Sept. 30, 2025, the firm managed approximately $244 billion in assets.

The company offers a